Objective: This article reopens the issue of a medical practice that has been well established for more than three decades by proposing an extension of the period during which treatment with the “morning-after” pill is currently prescribed. The objective is to determine the effectiveness of the regimen of Yuzpe and Lancee when it is administered between 72 and 120 hours after sexual intercourse. Study Design: We conducted an observational study comparing 2 groups of women for whom the regimen of Yuzpe and Lancee was administered after unprotected sexual intercourse. One group (usual time frame treatment group) sought consultation within 72 hours (n = 131), and the other (extended time frame treatment group) after 72 to 120 hours (n = 169). Results: The pregnancy rate was 0.8% for the <72-hour group and 1.8% for the 72- to 120-hour group. The effectiveness rate varied from 87% to 90% for the <72-hour group and from 72% to 87% for the 72- to 120-hour group. In both groups the χ 2 tests showed that emergency contraceptive pills significantly reduced the risk of pregnancy. Conclusions: Women should be encouraged to seek consultation as quickly as possible after unprotected sexual intercourse. However, if the usual time limit (<72 hours) has expired, the so-called “morning-after” pill should be recommended if an intrauterine contraceptive device is not available. Emergency contraceptive pills have a favorable success rate after 72 hours, with a pregnancy rate that is significantly lower than would be expected if no contraceptive were administered. (Am J Obstet Gynecol 2001;184:531-7.)
American Journal of Obstetrics and Gynecology – Wolters Kluwer Health
Published: Mar 1, 2001
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera